The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has published Drug Safety Update Issue 3 (PDF).
This third issue contains the following drug safety advice articles:
Piroxicam: new restrictions, including specialist initiation
Ketoprofen and ketorolac: gastrointestinal risk
Inhaled corticosteroids: pneumonia
Pneumovax II: tolerability of re-vaccination
Bisphosphonates: osteonecrosis of the jaw
Lorazepam: reduction of recommended maximum daily dose
In addition, this issue contains hot topics focussing on rare but serious risks posed by botulinum toxin products and cardiovascular safety and fracture risk update rosiglitazone and pioglitazone and a pointer to the prescribing update regarding hepatotoxicity with lumiracoxib.
Thanks Matt
No comments:
Post a Comment